Home › Funds › ORBIMED ADVISORS LLC › SION
ORBIMED ADVISORS LLC position in SION
SIONNA THERAPEUTICS INC · Health Care
ORBIMED ADVISORS LLC reported holding 2,555,877 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$112.4M, representing 2.26% of its reported portfolio and ranking #8 among its reported holdings. ORBIMED ADVISORS LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's SION position evolved
ORBIMED ADVISORS LLC first disclosed a stake in SION in Q1 2025 at 3,704,959 shares (US$38.8M). The position peaked in Q4 2025 at 3,561,655 shares, worth US$146.5M. Across 6 filings, ORBIMED ADVISORS LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,555,877 shares valued at US$112.4M — a reduction of -974,825 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2026 (shares fell 88% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.70M | $38.75M | New |
| Q2 2025 | 3.70M | $64.28M | Hold |
| Q3 2025 | 3.70M | $108.96M | Hold |
| Q4 2025 | 3.56M | $146.53M | Reduce |
| Q1 2026 | 3.53M | $141.55M | Reduce |
| Q2 2026 | 2.56M | $112.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SION and 13F data
SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SION
- RA CAPITAL MANAGEMENT, L.P. 9.91M sh · $435.72M · Q2 2026
- TPG GP A, LLC 6.49M sh · $285.71M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.00M sh · $131.78M · Q2 2026
- Enavate Sciences GP, LLC 2.48M sh · $109.01M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K sh · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K sh · $29.95M · Q2 2026
- Siren, L.L.C. 610.51K sh · $26.86M · Q2 2026
- Casdin Capital 400.00K sh · $17.60M · Q2 2026
- Kalehua Capital Management LLC 197.07K sh · $8.67M · Q2 2026
- Sofinnova Investments, Inc. 144.43K sh · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K sh · $5.98M · Q2 2026
- Sio Capital Management, LLC 127.81K sh · $5.62M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held SION?
ORBIMED ADVISORS LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is ORBIMED ADVISORS LLC's current position in SION?
As of Q2 2026, ORBIMED ADVISORS LLC holds 2.56M shares of SION (SIONNA THERAPEUTICS INC), valued at $112.43M, representing 2.26% of its reported portfolio and ranking #8.
Has ORBIMED ADVISORS LLC been buying or selling SION?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in SION. The position peaked in Q4 2025 at 3.56M shares.
Which other funds hold SION?
Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.